Complicated skin and soft tissue infection (Q37793714)

23 August 2017

Complicated skin and soft tissue infection (English)

1 reference

23 August 2017

Matthew S Dryden

1

1 reference

PubMed ID

20876627

23 August 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

Journal of Antimicrobial Chemotherapy

23 August 2017

1 reference

23 August 2017

65 Suppl 3

1 reference

23 August 2017

iii35-44

1 reference

Complicated infections of skin and skin structures: when the infection is more than skin deep

23 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Practice guidelines for the diagnosis and management of skin and soft-tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

“Celbenin” - resistant Staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Three-year surveillance of community-acquired Staphylococcus aureus infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

MRSA carriage in healthcare personnel in contact with farm animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Use of the bacteriology laboratory to decrease general practitioners' antibiotic prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Necrotizing fasciitis: case report and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

High diversity of Panton-Valentine leukocidin-positive, methicillin-susceptible isolates of Staphylococcus aureus and implications for the evolution of community-associated methicillin-resistant S. aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Effect of antibiotics on Staphylococcus aureus producing Panton-Valentine leukocidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Superantigens and streptococcal toxic shock syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Clinical Presentation and Bacteriologic Analysis of Infected Human Bites in Patients Presenting to Emergency Departments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Hospitalization due to Pasteurella multocida-infected animal bite wounds: correlation with inadequate primary antibiotic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Management of fever in patients with cancer and treatment-induced neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ302

21 January 2018

Identifiers

DOI

10.1093/JAC/DKQ302

1 reference

23 August 2017

1 reference

PubMed ID

20876627